Anwesha Naskar

Regulatory CMC Professional | Cell & Gene Therapy | Biologics

About

Biotechnology professional with 3+ years of experience in cell and gene therapy, specializing in CMC regulatory documentation, cGMP manufacturing, and quality systems. Experienced in working with US FDA and CDSCO submissions, with a strong foundation in molecular biology and biologics development.

Experience

Research Associate

Authored cGMP documentation including BMRs for NK cell therapy platforms. Contributed to CMC sections for US FDA and CDSCO submissions. Led QMS activities, standardized QC workflows, and supported scale-up of lentiviral vector production.

Scientist

Developed allogeneic NK cell platforms for CMC programs. Optimized scalable manufacturing and analytical methods for release and stability testing. Contributed to IND and MA regulatory documentation for CAR-T therapies.

Project Associate-I

Worked on HFSP-funded RNA World project involving construct design, IVTT, ribozyme synthesis, and molecular optimization. Managed lab operations, procurement, and grant coordination.

Education

Integrated M.Sc. in Science (Chemistry Major)

Key Work & Projects

Developed autologous and allogeneic NK cell platforms with focus on CMC, regulatory documentation, and scalable manufacturing under cGMP conditions.

Conducted advanced molecular biology experiments including STITCH PCR, IVTT systems, and RNA synthesis to study early molecular evolution mechanisms.

Skills

Technical Cell Culture, Flow Cytometry, Molecular Biology, Lentiviral Vectors
Regulatory CMC Documentation, IND/MA Submissions, US FDA, CDSCO, cGMP, QMS
Tools Documentation Systems, Data Analysis, Lab Management

Awards